170 related articles for article (PubMed ID: 33369214)
1. Heteroaromatic Inhibitors of the Astacin Proteinases Meprin α, Meprin β and Ovastacin Discovered by a Scaffold-Hopping Approach.
Tan K; Jäger C; Körschgen H; Geissler S; Schlenzig D; Buchholz M; Stöcker W; Ramsbeck D
ChemMedChem; 2021 Mar; 16(6):976-988. PubMed ID: 33369214
[TBL] [Abstract][Full Text] [Related]
2. Tertiary-Amine-Based Inhibitors of the Astacin Protease Meprin α.
Tan K; Jäger C; Schlenzig D; Schilling S; Buchholz M; Ramsbeck D
ChemMedChem; 2018 Aug; 13(16):1619-1624. PubMed ID: 29927060
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationships of pyrazole-based inhibitors of meprin α and β.
Tan K; Jäger C; Geissler S; Schlenzig D; Buchholz M; Ramsbeck D
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2165648. PubMed ID: 36661029
[TBL] [Abstract][Full Text] [Related]
4. First insight into structure-activity relationships of selective meprin β inhibitors.
Ramsbeck D; Hamann A; Schlenzig D; Schilling S; Buchholz M
Bioorg Med Chem Lett; 2017 Jun; 27(11):2428-2431. PubMed ID: 28408220
[TBL] [Abstract][Full Text] [Related]
5. Mammalian plasma fetuin-B is a selective inhibitor of ovastacin and meprin metalloproteinases.
Karmilin K; Schmitz C; Kuske M; Körschgen H; Olf M; Meyer K; Hildebrand A; Felten M; Fridrich S; Yiallouros I; Becker-Pauly C; Weiskirchen R; Jahnen-Dechent W; Floehr J; Stöcker W
Sci Rep; 2019 Jan; 9(1):546. PubMed ID: 30679641
[TBL] [Abstract][Full Text] [Related]
6. Insights from Analysis of Binding Sites of Human Meprins: Screening of Inhibitors by Molecular Dynamics Simulation Study.
Chaudhuri A; Bera AK; Sarkar I; Chakraborty S
Comb Chem High Throughput Screen; 2016; 19(3):246-58. PubMed ID: 26875789
[TBL] [Abstract][Full Text] [Related]
7. A Primary Evaluation of Potential Small-Molecule Inhibitors of the Astacin Metalloproteinase Ovastacin, a Novel Drug Target in Female Infertility Treatment.
Körschgen H; Jäger C; Tan K; Buchholz M; Stöcker W; Ramsbeck D
ChemMedChem; 2020 Aug; 15(16):1499-1504. PubMed ID: 32946206
[TBL] [Abstract][Full Text] [Related]
8. Structure and Dynamics of Meprin β in Complex with a Hydroxamate-Based Inhibitor.
Linnert M; Fritz C; Jäger C; Schlenzig D; Ramsbeck D; Kleinschmidt M; Wermann M; Demuth HU; Parthier C; Schilling S
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073350
[TBL] [Abstract][Full Text] [Related]
9. Human meprin alpha and beta homo-oligomers: cleavage of basement membrane proteins and sensitivity to metalloprotease inhibitors.
Kruse MN; Becker C; Lottaz D; Köhler D; Yiallouros I; Krell HW; Sterchi EE; Stöcker W
Biochem J; 2004 Mar; 378(Pt 2):383-9. PubMed ID: 14594449
[TBL] [Abstract][Full Text] [Related]
10. Structure-Guided Design, Synthesis, and Characterization of Next-Generation Meprin β Inhibitors.
Ramsbeck D; Hamann A; Richter G; Schlenzig D; Geissler S; Nykiel V; Cynis H; Schilling S; Buchholz M
J Med Chem; 2018 May; 61(10):4578-4592. PubMed ID: 29694039
[TBL] [Abstract][Full Text] [Related]
11. Continuous assays for meprin alpha and beta using prolyl tripeptidyl aminopeptidase (PtP) from Porphyromonas gingivalis.
Schulze A; Wermann M; Demuth HU; Yoshimoto T; Ramsbeck D; Schlenzig D; Schilling S
Anal Biochem; 2018 Oct; 559():11-16. PubMed ID: 30098994
[TBL] [Abstract][Full Text] [Related]
12. The substrate degradome of meprin metalloproteases reveals an unexpected proteolytic link between meprin β and ADAM10.
Jefferson T; Auf dem Keller U; Bellac C; Metz VV; Broder C; Hedrich J; Ohler A; Maier W; Magdolen V; Sterchi E; Bond JS; Jayakumar A; Traupe H; Chalaris A; Rose-John S; Pietrzik CU; Postina R; Overall CM; Becker-Pauly C
Cell Mol Life Sci; 2013 Jan; 70(2):309-33. PubMed ID: 22940918
[TBL] [Abstract][Full Text] [Related]
13. Fetuin-A and cystatin C are endogenous inhibitors of human meprin metalloproteases.
Hedrich J; Lottaz D; Meyer K; Yiallouros I; Jahnen-Dechent W; Stöcker W; Becker-Pauly C
Biochemistry; 2010 Oct; 49(39):8599-607. PubMed ID: 20806899
[TBL] [Abstract][Full Text] [Related]
14. Discovery of the first potent and selective Mycobacterium tuberculosis Zmp1 inhibitor.
Mori M; Moraca F; Deodato D; Ferraris DM; Selchow P; Sander P; Rizzi M; Botta M
Bioorg Med Chem Lett; 2014 Jun; 24(11):2508-11. PubMed ID: 24767848
[TBL] [Abstract][Full Text] [Related]
15. Activation of the epithelial sodium channel by the metalloprotease meprin β subunit.
Garcia-Caballero A; Ishmael SS; Dang Y; Gillie D; Bond JS; Milgram SL; Stutts MJ
Channels (Austin); 2011; 5(1):14-22. PubMed ID: 20953144
[TBL] [Abstract][Full Text] [Related]
16. Discovery of a 2,4-diphenyl-5,6-dihydrobenzo(h)quinolin-8-amine derivative as a novel DNA intercalating topoisomerase IIα poison.
Kunwar S; Hwang SY; Katila P; Park S; Jeon KH; Kim D; Kadayat TM; Kwon Y; Lee ES
Eur J Med Chem; 2021 Dec; 226():113860. PubMed ID: 34597897
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel 4-azaaryl-N-phenylpyrimidin-2-amine derivatives as potent and selective FLT3 inhibitors for acute myeloid leukaemia with FLT3 mutations.
Long Y; Yu M; Ochnik AM; Karanjia JD; Basnet SK; Kebede AA; Kou L; Wang S
Eur J Med Chem; 2021 Mar; 213():113215. PubMed ID: 33516985
[TBL] [Abstract][Full Text] [Related]
18. A kinetic comparison of the homologous proteases astacin and meprin A.
Wolz RL
Arch Biochem Biophys; 1994 Apr; 310(1):144-51. PubMed ID: 8161197
[TBL] [Abstract][Full Text] [Related]
19. Development of high throughput screening assays and pilot screen for inhibitors of metalloproteases meprin α and β.
Madoux F; Tredup C; Spicer TP; Scampavia L; Chase PS; Hodder PS; Fields GB; Becker-Pauly C; Minond D
Biopolymers; 2014 Sep; 102(5):396-406. PubMed ID: 25048711
[TBL] [Abstract][Full Text] [Related]
20. Pharmacophore modeling coupled with molecular dynamic simulation approach to identify new leads for meprin-β metalloprotease.
Chaudhuri A; Hudait N; Chakraborty SS
Comput Biol Chem; 2019 Jun; 80():292-306. PubMed ID: 31054542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
